Kidney transplantation (KTx) is the treatment of choice for end-stage renal disease [1]. Compared with dialysis it confers a survival advantage, enhances quality of life and is more cost-effective. There are two types of potential donors in renal transplants: deceased and living donors. Transplantation from living donors provides better survival rates in comparison to those from deceased ones [...

introduction although renal transplantation from cadaver is common, living donors continue to be an important source of transplanted kidneys. recipients of living-donor kidneys demonstrate improved graft survival. in this study, we evaluated the outcomes of renal transplantation from cadaver, related donors and unrelated donors in isfahan. methods we evaluated all of the patients who underwent ...

Peculiarities of the induction immunosuppressive therapy in renal transplantation

background multiple renal arteries in kidney grafts have been associated with an increased rate of vascular and urologic complications. our objective is to compare the outcome of transplanted patients who receive a single pedicle kidney with those who receive a multiple arterial graft. objectives to find our the differences in the outcome and complications in patients undergoing kidney transpla...

objectives: the present study aimed to provide an estimation of the current financial burden of renal transplantation therapy for insurance organisations.methods: an excel-based model was developed to determine the treatment costs of current clinical practice in renal transplantation therapy (rtt). inputs were derived from ministry of health and insurance organizations` database, hospital and p...

The vascular network is a major target of ischemia-reperfusion, but has been poorly investigated in renal transplantation. The aim of this study was to characterize the remodeling of the renal vascular network that follows ischemia-reperfusion along with the most highly affected cortex section in a preclinical renal transplantation model. There were two experimental groups. The first was a graf...

Kidney Transplantation in children is the treatment of choice to treat end stage renal disease. Improvements in immunosuppressive management have dramatically reduced the risk of early acute rejection and graft loss, however the long term results in terms of graft survival and morbidity still require search for new immunosuppressive regimens. Reducing of side effects are the challenges for impr...

We have used recombinant human erythropoietin (r-HuEPO) in children with chronic renal failure. There was significant improvement in anemia and wellbeing, along with regression of left ventricular mass and no change in the rate of decline of renal function. It is safe and effective in the pre-dialysis as well as the hemodialysis period. Considering the benefits of r-HuEPO, transplantation i...

Background: The higher frequency of malignant skin tumors is of great significance in renal transplant recipients (RTRs) who should receive immunosuppressive therapy for a long time. This study was designed to determine the frequency of malignant skin tumors in RTRs in Imam Reza Hospital, Mashhad, Iran, in 2001-2002.Method: This descriptive study was performed on 322 recipients who were examine...